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UTHEALTH QUALITY SYMPOSIUM 2022 ABSTRACTS-2, HOUSTON, TX
Poster 9: Evaluation of penicillin allergy labeling at Lyndon B. Johnson Hospital
Laurent Ehrlich, Serena Zadoo, Irfan Ali, Raman Bamidele, Eric Fris, Leonardo Villarreal
Aguirre, Lyndon Lee, Dr. Gabriel Aisenberg
1

University of Texas Health Science Center at Houston, 7000 Fannin St, Houston, TX – 77030

Emerging evidence suggests that patients with listed drug allergy have inferior outcomes than
patients without listed drug allergies. Unverified penicillin allergy can lead to utilizing less
efficacious antibiotics, increased length/cost of hospital stay, and adverse effects including
antibiotic resistance and Clostridium difficile infections. Reports of penicillin allergy seldom
reflect tested allergy. ~0.2% of patients that undergo drug allergy testing are truly allergic to the
listed medication. This project’s first aim was to assess the prevalence of penicillin allergy label
in the Lyndon B. Johnson Hospital patient population: we found a 1.2% prevalence. We
evaluated the reaction types and the most common reactions were rash (26%), hives (16%),
angioedema/swelling (10%), and anaphylaxis (4%) – these values correlate with findings of a
large, urban outpatient population. The most common subtype (36%) was
undocumented/unknown reaction. There was a statistically significant difference in proportions
of C. diff, MRSA, and VRE infections (p<0.001) between patients with penicillin allergy label
and without. Our data demonstrates a need for awareness and education regarding a complete
drug allergy history. Most acute care hospitals, including LBJ Hospital, lack access to allergy
specialists and penicillin allergy diagnostic testing. It is imperative that all providers have
awareness of drug allergy assessments given the implications of unverified drug allergy labels
and the fact that it is possible to de-label patients based on history alone. Part II of our study will
focus on resident education of accurate drug allergy history/assessment to identify patients
without IgE-mediated allergy and de-labeling.
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Poster 10: Bone Health Monitoring and Management in Inflammatory Bowel Disease
Patients in the Harris Health Gastroenterology Specialty Clinic.
Sruthi Kapliyil Subramanian MD, Austin Thomas MD, Azaan Ramani DO, Adrianne Tsen MD,
Asmeen Bhatt MD PhD, Scott Larson MD PhD FASGE
Department of Gastroenterology, Hepatology and Nutrition McGovern Medical School at
UTHealth, Houston, Texas.
Introduction
Approximately 1.4 million people in the United States suffer from inflammatory bowel disease
(IBD) and are at higher risk of developing osteoporosis and osteopenia than the general
population. The prevalence of osteopenia and osteoporosis in patients with IBD ranges from
22%-77% and 17%-41%, respectively, with a 40 % higher relative risk of fracture. It is
imperative that physicians recognize patients at risk for osteoporosis, screen appropriate patients,
and prevent or treat accordingly. The primary objective of this study is to assess and improve the
quality of bone health monitoring and management, which include both Vitamin D level and
Dual-energy X-ray absorptiometry (DEXA) scan evaluation in patients with IBD in Harris
Health (HH) Gastroenterology specialty (GI) clinic.
Method:
We retrospectively evaluated a total of 116 IBD patients seen in HH GI clinic from February
2019 to March 2020. We assessed the number of patients who had undergone DEXA scan and
had their vitamin D level checked during clinic visits, which was found to be below the national
standards. We developed a smart phrase (.IBDPH – Table 1) for electronic medical records,
including the criteria for bone health screening and surveillance, vaccines in IBD, cancer
surveillance, and nutritional management. This smart phrase also outlines the interval of bone
health surveillance and provides a protocol for managing osteoporosis /osteopenia, making it
easy for the team to implement it in a busy clinic. Each IBD patient chart is followed up after the
clinic to assess if the smart phrase was used and protocol followed. Data was then prospectively
collected for the month of July to November 2021.
Result:
Of 116 patients evaluated retrospectively from February 2019 to March 2020, 58 had undergone
DEXA scan (50%) and 58 did not (50%). Of the 58 patients who underwent DEXA scan, 10 had
osteoporosis (17.2%), 19 had osteopenia (32.8%) and 29 had normal bone density (50%).
Vitamin D was checked in 98 patients (84.4%). There were 3 patients (2.5%) who developed
fracture due to decreased bone density.
After the intervention in July 2021, 85 IBD patients were evaluated prospectively. Of the 85
patients, 73 patients (85.9%) had current DEXA scans, and 81 patients (95.3%) had current
vitamin D levels. 13 (21%) patients were identified with osteoporosis and 27 (43.5) patients were
identified with osteopenia. Both the study characteristics are summarized in table 2.
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Conclusion:
With our intervention, we were able to increase DEXA scan compliance to 85.9% from 50%
which translated into appropriate referral and treatment. We were able to identify the patients
who are having osteopenia and initiate treatment to prevent osteoporosis and fracture which
drastically improved the quality of life for these patients.
Table 1. IBD Preventive health smart phrase
1) Vaccination History
A. Hep A and Hep B immunity status:
- Check Anti- HBs total and Anti HAV to check for immunity if patient had
vaccine before.
- If non immune - Twinrix vaccine - First dose- Month 0 ***, Second dose Month 2***, Third dose - 6 months***
B. Annual influenza: Every year***
C. Prevnar 13 and PPSV23 history: As per guidelines
D. Tdap history: Within 10 years***
E. HZ Vaccination history: Dose 1 - Day 0***, Dose 2: 2-6 Months from first dose ***
2) Bone density evaluation
A. Last Vit D 25 OH level: Check every year ***
B. Last DEXA Scan: ***
- Baseline at the time of diagnosis or within 1 year
- Every 2 yr if patient has osteoporosis at initial DXA scan and every year if they are
being treated for osteoporosis.
- Normal initial Dexa Scan - Check every 2-3 years in patients with risk factors
(postmenopausal female, males more than 50 yr of age, history of vertebral fractures,
steroid use within the prior 3 m, inactive disease but chronic steroid use of at least 1 yr
in the prior 2 yr, inactive disease but maternal history of osteoporosis, inactive disease
but malnourished or very thin, inactive disease but with amenorrhea).
Current Treatment: Mention Vitamin D replacement and osteoporosis treatment ***
3) Colorectal Cancer surveillance: ***
4) Tobacco Cessation: ***
5) Last QuantiFERON-TB Gold test: ***

Table 2. The study characteristics of retrospective and prospective analysis
Characteristics
Retrospective data (N- 116)
Prospective data (N-85)
Age
46 +/- 12
47 +/- 17
Sex
Male – 57
Male – 49
Female – 59
Female – 36
Ethnicity

Caucasian – 36
African American – 15
Hispanic – 56
Other- 9

Caucasian – 17
African American – 19
Hispanic – 41
Other- 8

BMI

27 +/- 6

28 +/- 6
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Type of IBD

Crohn’s disease – 44
Ulcerative colitis – 72

Medications

Biologics- 87
Immunomodulators – 27
Steroids – 15
5-ASA – 49
Done – 58 (50%)
Not done – 58 (50%)
Osteoporosis – 10 (17.2%)
Osteopenia – 19 (32.5%)
Normal bone density- 29
(50%)
Checked – 98
Not checked – 18
Present – 3
Not present – 113

DEXA scan
DEXA scan result

Vitamin D
Fracture

https://digitalcommons.library.tmc.edu/j_tic/vol1/iss1/5

Crohn’s disease – 21
Ulcerative colitis – 61
Indeterminate colitis - 3
Biologics- 67
Immunomodulators – 21
Steroids – 43
5-ASA – 51
Ordered – 73 (85.9%)
Not ordered – 12 (14.1%)
Osteoporosis – 13 (21%)
Osteopenia – 27 (43.5%)
Normal bone density- 22
(35.5%)
Checked – 81 (95.3)
Not checked – 4 (4.7)
Present – 3
Not present – 82
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Poster 11: Improving Resident Education and Comfort with the EHR (Care4)
Jillian L. Smith MD1, Sarika Ziemann DO2, Bradley Roche MD2, Ramanjit Kaur MD2, Steffi Hu
MD2, Eric Yoon MD2, Mohammad Alsheikh-Kassim MD2, Ailinh Do MD1, Abraham Lee MD2,
Justin Salman DO2, Christina Haddad MD2, Serena Zadoo MD2, Jeffrey Chen MD3 and Amee
Amin MD, CMQ3
1
University of Texas Health and Science Center at Houston (UT Health), Houston, TX Department of Internal Medicine-Pediatrics
2
University of Texas Health and Science Center at Houston (UT Health), Houston, TX Department of Internal Medicine
3
University of Texas Health and Science Center at Houston (UT Health), Houston, TX Department of Emergency Medicine, Hospitalist Division
Overview/Problem Statement:
Most of a resident’s day is spent on our EMR Care4 for patient care and documentation, though
we receive only 8 hours of formal Care4 training during intern orientation. Our aim is to develop
standardized teaching for residents to improve both proficiency and efficiency.
Methods:
1. Pre-Survey given to Internal Medicine and MedPeds residents in 9/2021
2. Created a resident Care4 Guide available to residents through UT Share Drive
3. Delivered “Care4 Tips and Tricks” talk during resident noon conferences (1/31/22,
4/8/22, 4/25/22)
4. Post-Survey given to residents who attended our talks
Results:
Pre-intervention survey:
Results from 51 respondents. On a scale of 1-5, usefulness of existing Care4 training was 2.3;
comfort level after 1 month was 3.4. 35% of respondents didn’t feel confident until after 12
months. Only 60% of residents can add problems to a problem list, only 65% feel comfortable Eprescribing medications, and only 70% feel confident placing home health orders.
Post-intervention Survey:
Results from 29 respondents (41% interns). On a scale of 1-5, helpfulness of the Care4 Guide
was rated 4.5. Confidence in Care4 use increased from 4.0 to 4.7 after intervention. Figure 1
demonstrates self-reported knowledge of specific Care4 tasks from pre-survey and post-survey.
Conclusions:
Post-survey results show that a resident created Care4 Guide and “tips and tricks” talks during
noon conference are effective in increasing resident confidence in Care4. Future PDSA cycles
include rigorous training during intern orientation and monthly talks for reinforcement.
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Figure 1: Knowledge of Tasks Before and After Care4 Teaching Session
Before data from Pre-Intervention Survey (09/2021).
After data from Post-Intervention Surveys given multiple dates after teaching sessions (1/31/22,
4/8/22, 4/25/22).
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Poster 12: A Risk Adapted Strategy for Prevention of Tumor Lysis Syndrome (TLS): A
Quality Improvement (QI) Project
Wing, S1. MD, Yohannan, B2. MD, Rios, A2. MD
1. Department of Internal Medicine
2. Division of Hematology and Oncology
Background: TLS is a life-threatening oncologic emergency caused by increased spontaneous
or therapy-related destruction of tumor cells. The best treatment of TLS is prevention.1,2 Our QI
project objective is to prevent TLS by adhering to a protocol-based preventive approach using a
standardized medical order set based on a risk-adapted prevention strategy.
Method: We have created an algorithm to prevent TLS outlining risk stratification with
correspondent appropriate steps for each risk category. Patients at TLS risk are stratified into
low, intermediate, and high-risk categories based on the underlying disease, WBC count, LDH,
uric acid, renal function, and treatment modality. We are developing a computerized easy-to-use
order set for TLS prevention collaborating with the Information Technology Department of
Memorial Hermann at the Texas Medical Center. The order set will provide correspondent
measures for each risk category including uric acid lowering therapies, specific fluids and
electrolytes management, and laboratory monitoring. Using a schedule of consistent live
presentations and a permanent easy access audio-visual tools for teaching strategy, we will
educate providers on how to use the orders set in patients at risk for TLS.
Data Collection: The data collection will capture the incidence of TLS among hospitalized
patients at MHTMC before (CY 2020-2022) and after incorporation of the order set. We
hypothesize that a standardized evidence-based protocol should significantly reduce the
incidence of TLS.
Conclusion: TLS is a common preventable oncological emergency. The implementation of a
standardized order set for prevention of TLS should improve the care of patients at risk of TLS.
References
1. Cairo, M. S., Coiffier, B., Reiter, A., Younes, A., & TLS Expert Panel. (2010).
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS)
in adults and children with malignant diseases: An expert TLS panel consensus. British
Journal of Haematology, 149(4), 578-586. doi:10.1111/j.1365-2141.2010.08143.x
2. Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of
pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of clinical
oncology. 2008;26(16):2767-2778.
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Poster 13: Case of the Mondays: Analysis of Day To Day GI Lab Utilization in a Safety Net
Population
Tanmay Gaglani, MD; Keith R. Garrison, MD; Chase Miller, MD; Muhammed Vohra, MD;
Nina Quirk MS3; Sean Ngo MS1; Scott Larson, MD PhD
Introduction: Lyndon Baines Johnson General Hospital (LBJ) is one of the two major hospitals
operated by the Harris Health System, a government entity that provides healthcare to the
uninsured and underinsured population. Resource utilization is a key quality metric in this
system as inefficiencies can reduce the accessibility of care. The no show rate for the LBJ
outpatient GI lab was assessed to identify trends in patient’s not completing outpatient
endoscopic procedures.
Methods: Included patients needed to have completed a GI clinic appointment, conducted
anesthesia screening, conducted COVID testing and not have been present for their outpatient
endoscopic procedure. The no show rates were subsequently stratified based upon the days of the
week to assess if a certain day was preferentially sub-optimized from a utilization perspective.
Results: Data was collected from 1761 endoscopic procedures conducted in the study period
from January 2021- December of 2021(Figure 1). When compared to other weekdays, patients
were 2.93 times more likely not to show for endoscopy on Mondays (P<0.001).
Conclusions: There may be various factors influencing the increased rate of attrition on
Mondays. We plan to conduct further quality improvement interventions including
implementation of text message reminders or Thursday morning phone calls for Monday
procedures.
Figure 1:
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Poster 14: Improving Resident Involvement in Variance Reporting
Jillian L. Smith, MD1, Natasha Maqsood, MD1, Farhana Khaja, MD1, Albert Heo, MD1, Mahsa
Madani, MD1, Jordan Killingsworth, MD1, Ailinh Do, MD1, Emmanuel Avelino, MD1, Ryan Le,
MD1, Irfan ‘Simon’ Ali, DO1, Evan Abdullah, MD1, James Barnett, MD1, Reid Davison, MD1,
Roberto Garcia, MD1, Alexia Jauregui, MD1, Emily Leong, MD1, Yadier Brito-Cuas, MD1,
Hoanganh Đoàn, MD1, John S Lane, DO1, Suraj Patel, MD1, Anish Patnaik, MD1, Michael
Romagosa, MD1, Alveena Altaf, MD1, Annirudh Balachandran, MD1, Hannah Burson, MD1,
Joanne Kim, MD1, Omare Okotie-Eboh, MD1, Ariel Osorio, MD1, Kelsey Carnahan, MD1,
Nadine Gordon, MD1, Tuong Phan, MD1, Azhar Shah, DO1, Phyllis Martin, Mark Farnie, MD1,
Ariana Klein, MD1
1
University of Texas Health and Science Center at Houston (UT Health), Houston, TX Department of Internal Medicine-Pediatrics
Overview/Problem Statement:
Submitting safety events (Variance Reports) is a critical component of creating a culture of
safety, but few physicians (residents/fellows) are submitting variances. We aimed to increase
trainee participation in safety event submissions.
Methods:
● Surveyed Internal Medicine (IM) and Pediatrics (Peds) residents regarding Variance
submissions (1/2022)
● Developed a “Variance Teaching Session” presented during IM and Peds conferences
(1/31/22 and 2/4/22)
● “How to Variance” Cards placed on computers in IM/Peds workrooms (2/2022 - 3/2022)
● Obtained epidemiologic data from Variance submissions on reporting patterns (1/2021 3/2022)
Results:
Intro Survey: Results from 119 respondents. Only 34% have submitted a variance. IM/Prelim
residents were less likely to report knowing what a Variance was (75% v. 92% Peds), less likely
to know how to submit (26% v. 46% Peds) and less likely to have reported submitting (12% v.
41% Peds).
Barriers to submission: Knowing where to submit, lengthiness of submission form, time needed
to submit, fear of retaliation, and unclear outcomes from submissions
Variance report data: Over 15 months (01/2021 - 03/2022) mean TMC-MHH submissions (per
month) μ = 775, Physician submissions μ= 3. Major Categories: 49% Care Management, 16%
Professionalism, 12% Medications. 49% Physician submissions were reported by
residents/fellows, and of those 62% were Peds and 20% IM.
Conclusions:
Our intervention walked residents through the steps of submitting Variances. Variance reporting
data showed that resident/fellow reporting increased after our interventions, though IM residents
were still less likely to report than Peds residents.
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Figure 1: Variance Run Chart
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Poster 15: Measuring the educational effect of transforming the Morbidity and Mortality
conference into a “Culture of Safety” conference
Lindsey Farmer, Nathan Box, Jorge Irizarry-Caro, Maneera Chopra, Akshitha Yarrabothula,
Austin Armstrong, Christen Dillard, Kelly Galvis, Raamis Khwaja, Saradadevi Thanikachalam,
Amee Amin, Omowunmi Aibana
Background: All residencies are required to host Morbidity and Mortality conferences (M&Ms)
as a key piece of the quality improvement curriculum. Traditional M&Ms have a negative
connotation from the resident perspective. The UT Houston Internal Medicine (IM) residency
rebranded their M&Ms to “Culture of Safety” (CoS) conferences in order to promote a safe
educational environment for the peer review process. The goals of this change were to prompt
open discussion and critical review of adverse events, increase awareness among IM residents
about quality improvement processes, and identify actionable solutions to prevent future errors.
Methods: CoS conferences were carried out in a standardized format using the following
structure: overview CoS goals, review of the previous case, presentation of the current case (with
involved residents remaining anonymous), small and large group discussions, and presentation
by a faculty member over a related medical learning point. Surveys were administered via
Qualtrics before and after the conferences to measure changes in participant confidence in
managing the topic at hand.
Results: The percent of participants reporting an improvement in confidence to manage the topic
reviewed at each conference increased in the post surveys (Table 1). We identified barriers
related to low survey participation rates.
Conclusions: Overall, the educational piece of CoS conference was effective in this new format.
Further studies on resident satisfaction are warranted.
Table 1. Survey results for individual conferences with “Positive response” (i.e. Score ≥ 3 on 5point graded scale)
PrePostconference
conference
Date Topic
Survey
Survey
Management of hypercapnic respiratory failure, Beers
9/13 criteria, and safe handoffs

n=11

n=7

Positive responses to "How comfortable are you with acute
hypercapnic respiratory failure?"

36.36%

85.71%

Positive responses to "How comfortable are you prescribing
high- risk medications in the elderly?"

18.18%

57.14%

Positive responses to "How comfortable are you escalating
care/transferring to the MICU?"

45.45%

71.43%

n=7

n=27

10/4 Management of advanced vascular access
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Positive responses to "How comfortable are you with
recognizing the different types of advanced vascular access,
the indications for each, and when to remove them?"

Not asked

Positive responses to "Do you feel this conference helped your
knowledge of the lines used for hemodialysis?"
Not asked

85.19%

Positive responses to "After having this conference how do
you feel that your ability to identify lines in a patient and
manage them has changed?"

Not asked

96.30%

n=24

n=27

Positive responses to "How comfortable do you feel
recognizing early oliguric renal failure?"

45.83%

66.67%

Positive responses to "How comfortable do you feel placing
central lines in the medicine floors?"

20.83%

29.63%

Positive responses to "I feel confident managing the care of a
patient with a pacemaker."

16.67%

Not asked

Positive responses to "How useful was this presentation?"

Not asked

85.19%

n=25

n=6

Positive responses to "How comfortable are you with
managing tumor lysis syndrome on the floors?"

16.00%

16.67%

Positive responses to "How comfortable are you with
managing differentiation syndrome on the floors?"

4.17%

0.00%

Positive responses to "How comfortable are you with
managing leukostasis on the floors?"

12.00%

0.00%

Positive responses to "How comfortable are you with
managing DIC on the floors?

24.00%

33.33%

Patient level of care when admitting from the emergency
room

n=27

n=13

Positive responses to "I understand the difference between
observation and inpatient status"

70.37%

92.31%

Positive responses to "When you disagree with the ED
regarding either an admission or the patient status (floor vs
IMU vs ICU), do you feel comfortable discussing this with
them?"

48.15%

Not asked

Management of oliguric renal failure and patients with
12/6 pacemakers requiring central access

1/10 Management of oncologic emergencies

2/7

0.00%

Positive responses to "I feel confident that I would know what
to do if I disagreed with the ED regarding either an admission
or the patient status (floor vs IMU vs ICU)."
Not asked
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Poster 16: Reducing 0-7 Day Hospital Readmissions Through Improving Inpatient to
Outpatient Care Coordination
Samuel Mackoff, MD
Hospital readmissions are an important complication of inpatient care as they have a significant
impact on patient outcomes and resource consumption.1,2,3 The Better Outcomes for Older
Adults Through Safe Transitions (BOOST) score is a risk assessment tool used to reduce hospital
readmissions. In this project, we seek to use the BOOST score to examine common
characteristics among readmissions to academic general medicine teams at Memorial Hermann
Hospital. Retrospective chart review of 0-7 day readmissions between May and October 2021
revealed the most common barriers to be physical limitations (61%), polypharmacy (55%), and
afternoon discharge (66%). We plan on further analyzing this data to determine additional
characteristics including most common diagnosis. We will then devise and implement an
intervention to better facilitate discharge planning for high risk patients with the goal of reducing
readmission rates among these teams by 50% within a 6-month period.

Durbin Jr, C.G. and Kopel, R.F., 1993. A case-control study of patients readmitted to the
intensive care unit. Critical care medicine, 21(10), pp.1547-1553.
Siddiqui, Z., Berry, S., Bertram, A., Allen, L., Hoyer, E., Durkin, N., Qayyum, R., Wick, E.,
Pronovost, P. and Brotman, D.J., 2018. Does Patient Experience Predict 30‐Day Readmission? A
Patient‐Level Analysis of HCAHPS Data. Journal of hospital medicine, 13(10), pp.681-687.
Upadhyay, S., Stephenson, A.L. and Smith, D.G., 2019. Readmission rates and their impact on
hospital financial performance: a study of Washington hospitals. INQUIRY: The Journal of
Health Care Organization, Provision, and Financing, 56, p.0046958019860386.
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Poster 17: Implementing a Standardized Electronic Medical Record Order Set to Reduce
Emergency Department Wait Times for Sickle Cell Patients in Acute Vaso-Occlusive Crisis
Ijele Adimora, Ugochi Ebinama, Alexandria Koney, Naveen Subramanian, Reid Davison, Ji Lin,
Evan Abdullah, Jordan Thomas, Shelby Irwin, Arthi Sridhar, Modupe Idowu
Background:
Sickle cell disease (SCD) is a hemoglobinopathy that gives rise to acute pain episodes. Vasoocclusive crises are the most common cause of emergency department (ED) visits and
hospitalizations for SCD, and have a significant effect on morbidity1.
Delay in appropriate pain control results in increased morbidity and decreased patient
satisfaction. Our project was designed to address prolonged wait times in the ED for SCD
patients presenting with acute vaso-occlusive crisis.
Methods:
We extracted data from FirstNet on patients seen at Memorial Hermann ED from JuneSeptember 2021 for acute vaso-occlusive crisis. We collected data on SCD genotype, ED checkin time, time at which intravenous fluids, non-opioid pain medications, and opioid medications
were administered, and patient disposition. Our intervention addressing current wait times is
ongoing. We intend to gather post-intervention data upon its conclusion.
Results:
Out of 75 patients with SCD, 30 (48%) received opioids prior to discharge. 14 (18.6%) patients
received a non-opioid pain medication, and 31 (41%) of patients did not receive any pain
medication prior to their disposition. The mean time of opioid administration was 5.44 hours,
and the median time was 4.12 hours. The mean time of non-opioid pain medication
administration was 4.65 hours, while the median time was 1.94 hours.
Conclusion:
The wait times for SCD patients at our institution are not in line with the current guidelines2,3
dictating management of acute vaso-occlusive crisis. It remains to be seen whether our
intervention can improve the wait times of SCD patients in the ED setting.
References:
Schatz, A. A., Oliver, T. K., Swarm, R. A., Paice, J. A., Darbari, D. S., Dowell, D., ... & Carlson,
R. W. (2020). Bridging the gap among clinical practice guidelines for pain management in
cancer and sickle cell disease. Journal of the National Comprehensive Cancer Network, 18(4),
392-399.
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Poster 18: Perspectives On Transition Readiness Among Youth With Sickle Cell Disease
and Their Caregivers
Tong Han Chung, PhD1, Carlos Orellana Garcia, BS2, Venée N. Tubman, MD, MMSc3, Yen-Chi
Le, PhD1, Stephanie Dixon, MBA1, Adrienne Finley, MPH, MS4, Modupe Idowu, MD5, and
Titilope Fasipe, MD, PhD3
1. Dept of Healthcare Transformation Initiative, McGovern Medical School, UTHSC-H
2. Dept of Preventive Medicine and Population Health, University of Texas Medical Branch
3. Texas Children’s Cancer and Hematology Centers, Baylor College of Medicine
4. Dept of Community Based Clinics, UTHSC-H
5. Dept of Internal Medicine, McGovern Medical School, UTHSC-H
Background: Disparate mortality rates in young adults with sickle cell disease (SCD)
correspond to poor outcomes during transition to adult care. To assess the baseline needs of our
local population, we measured transition readiness of youth with SCD and their caregivers.
Methods: This was a pilot study of youth with SCD and their caregivers at Texas Children’s
Hospital in 2021. Standardized transition readiness assessments (TRAs) were administered using
REDCap and scored on unique Likert scales: transition importance (0-10), transition confidence
(0-10), health and healthcare (0-40), and medicines (0-6). A mean score for each TRA section
was calculated for youth and caregivers, among matched cases. Wilcoxon signed-rank test was
performed to compare youth and caregiver scores. Correlations between these scores were
assessed using Spearman’s correlation coefficient.
Results: Eleven youth-caregiver dyads completed TRAs. Youth ranged in age from 14-19 years.
The mean scores of transition importance, transition confidence, health and healthcare, and
medicines among youth with SCD were 8.27, 5.82, 28.55, and 5.64, respectively. There were no
statistically significant differences between youth and caregiver TRA scores.
There was a positive correlation between youth transition confidence and caregiver transition
confidence, which was statistically significant (p=0.04). No significant correlations were
observed between youth and caregiver scores for other sections.
Conclusions: Transition readiness surveys provide an opportunity to assess perspectives of
youth with SCD and their caregivers to inform our transition-focused quality improvement goals.
The next steps are to gather additional surveys and organize stakeholder focus groups to enhance
transitions between pediatric and adult providers.
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Poster 19: Hyperbaric Oxygen Therapy (HBOT) for Irradiation Cystitis with Hematuria.
Joseph G. Nevarez, MD, Colett Asombang, NP-C
McGovern Medical School, UTHSC-H
Over 1 million people in the U.S. are diagnosed with invasive cancer annually. Approximately
half receive radiation therapy and ~ 5% will incur serious complications such as Irradiation
Cystitis (IRC) due to Late Effects of Radiation (LER). IRC can cause hematuria, urinary
obstruction, anemia and exacerbate comorbid conditions. There is no satisfactory conventional
treatment for IRC. Current treatment includes continuous bladder irrigation (CBI), transfusions,
bladder fulguration, nephrectomy, and cystectomy. These have significant potential
complications and are mostly only temporizing.
Hyperbaric Oxygen Therapy (HBOT) is approved by the Center for Medicaid & Medicare
Services for treatment of IRC. Studies have found improved symptoms and few side effects with
HBOT. Design and execution of randomized, controlled trials for HBOT are difficult and
adequate trials are lacking. The Undersea Hyperbaric Medical Society has encouraged reviews
to help support evidence of therapeutic effect with HBOT
Retrospective review of individuals who received HBOT for IRC due to LER. Patients who
completed HBOT were assessed for reduction of major events such as hematuria,
hospitalizations or invasive procedures as well as side effects or complications related to HBOT.
Primary:
HBOT reduced or eliminated need for all major interventions reviewed: ED visits,
hospitalizations, CBI, bladder fulguration, transfusions, nephrectomy, or cystectomy.
Secondary:
HBOT was not associated with known major side effects.
HBOT is an approved therapy which is safe and demonstrated reduced ER and hospital
admissions, transfusions and invasive procedures.
These findings should inform primary care physicians and specialists involved in the care of
patients suffering with IRC.
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Poster 20: Reducing Potential for Transmission of COVID-19 During Hyperbaric Oxygen
Therapy
Joseph G. Nevarez, MD, Colett Asombang, NP-C
McGovern Medical School, UTHSC-H
In Hyperbaric Oxygen Therapy (HBOT) patients breathe 100% oxygen via a self-contained
breathing apparatus, an "oxygen hood” within confines of an enclosed chamber. To decrease
oxygen toxicity risk, a rare but serious side effect, the hood is temporarily removed during a
planned “air break”. During an air break the patients and staff are in proximity and exposed to
shared chamber air.
COVID-19 is a novel coronavirus transmitted by respiratory droplets. Infected individuals may
be asymptomatic or minimally symptomatic, yet it is highly contagious with significant
morbidity and mortality. Risk of transmission during air-breaks, especially at the pandemic
onset, was not well known. Exposure of patient and staff in proximity during air breaks posed a
theoretical risk desirable to avoid while not increasing risk of oxygen toxicity.
The “Kindwall Treatment Table”, with no incorporated air breaks, was substituted for critical
patients normally prescribed U.S. Navy Treatment Table #5 at a depth of ~3 ATA. The air break
was eliminated without otherwise altering the standard “Wound Healing Treatment Table”
prescribed for non-emergent conditions requiring only 2ATA.
Primary:
We reviewed episodes of seizure with and without airbreaks.
Incidence of seizure:
without. air break - 1 seizure in 2145 treatments
with air break - 1 seizure in 3382 treatments
Secondary:
No seizures seen in either high risk group treated for carbon monoxide toxicity.
Number of HBOT prescribed was not affected.
Eliminating air-breaks did not appear to alter treatment effectiveness, is safe and a reasonable
measure to mitigate risk of COVID-19 transmission during HBOT.
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